Olivia Walch
Principal investigator.
Digital health
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$4.6MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $4.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 2, 2026 | NIH | STTR Phase II Real-world translation of a dynamic and personalized intervention for shift workers | $598K | Arcascope Inc. |
| Sep 2, 2026 | NIH | STTR Phase II Real-world translation of a dynamic and personalized intervention for shift workers | $598K | ARCASCOPE, INC |
| Aug 8, 2025 | NIH | STTR Phase II Real-world translation of a dynamic and personalized intervention for shift workers | $629K | Arcascope Inc. |
| Aug 8, 2025 | NIH | STTR Phase II Real-world translation of a dynamic and personalized intervention for shift workers | $629K | ARCASCOPE, INC |
| Jul 5, 2024 | NIH | STTR Phase II Real-world translation of a dynamic and personalized intervention for shift workers | $693K | Arcascope Inc. |
| Jul 5, 2024 | NIH | STTR Phase II Real-world translation of a dynamic and personalized intervention for shift workers | $693K | ARCASCOPE, INC |
| Sep 11, 2023 | NIH | STTR Phase I Feasibility of app-delivered circadian synchronization therapy with light in a cohort of pregnant women | $295K | Arcascope Inc. |
| Sep 11, 2023 | NIH | STTR Phase I Feasibility of app-delivered circadian synchronization therapy with light in a cohort of pregnant women | $295K | ARCASCOPE, INC |
| Feb 28, 2023 | NIH | STTR Phase I Feasibility of a mobile application for sleep and circadian rhythms in pediatric patients with acute lymphoblastic leukemia and their caregivers | $274K | Arcascope Inc. |
| Feb 28, 2023 | NIH | STTR Phase I Feasibility of a mobile application for sleep and circadian rhythms in pediatric patients with acute lymphoblastic leukemia and their caregivers | $274K | ARCASCOPE, INC |
| Mar 15, 2022 | NIH | STTR Phase I Assessment of mobile application-delivered lighting interventions for reducing circadian disruption in shift workers | $255K | Arcascope Inc. |
| Mar 15, 2022 | NIH | STTR Phase I Assessment of mobile application-delivered lighting interventions for reducing circadian disruption in shift workers | $255K | ARCASCOPE, INC |
| Jul 23, 2021 | NIH | SBIR Phase II Assessing the impact of app-delivered lighting interventions on fatigue in three populations of cancer patients | $739K | Arcascope Inc. |
| Jul 23, 2021 | NIH | SBIR Phase II Assessing the impact of app-delivered lighting interventions on fatigue in three populations of cancer patients | $739K | ARCASCOPE, INC |
| Sep 11, 2020 | NIH | SBIR Phase II Assessing the impact of app-delivered lighting interventions on fatigue in three populations of cancer patients | $873K | Arcascope Inc. |
| Sep 11, 2020 | NIH | SBIR Phase II Assessing the impact of app-delivered lighting interventions on fatigue in three populations of cancer patients | $873K | ARCASCOPE, INC |
| Sep 12, 2018 | NIH | SBIR Phase I Developing a mobile application for circadian wellness in cancer patients | $221K | Arcascope Inc. |
| Sep 12, 2018 | NIH | SBIR Phase I Developing a mobile application for circadian wellness in cancer patients | $221K | ARCASCOPE, INC |
1 patents as inventor
- US Arcascope Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#53
Awards as PI#37
Patents#45
Companies
- Arcascope Inc.Linked by awards
- ARCASCOPE, INCLinked by awards · Digital health
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.